Xendo and its affiliate, Sofus Regulatory Affairs AB have been acquired by ProPharma Group

We are pleased to announce Xendo Holding B.V. (“Xendo”) and its affiliate, Sofus Regulatory Affairs AB have been acquired by ProPharma Group, headquartered in Overland Park, Kansas, USA.

ProPharma Group is an industry leader in global medical information, pharmacovigilance, and compliance consulting services for the pharmaceutical, biotechnology, and medical device industries. By joining forces, we will be able to offer additional resources and expertise to our clients. This advantage will provide the opportunity to bring our portfolio of services to a larger market and further develop our operations.

ProPharma Group’s client mix of (bio)pharmaceuticals, medical devices, and healthcare parallels our existing client base. ProPharma Group’s service offerings and desire to grow their business make it an excellent enhancement for the company. The acquisition further expands Xendo’s footprint, offering the possibility to introduce all services of the combined company in new territories and provides further growth to ProPharma Group’s already established presence in the U.S., EU, Asia, and Australia. ProPharma Group is now an international, independent, single source provider of compliance-related services.

Interested in a regular update of the Life Sciences and biotech sector in Flanders?